Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors

Cancer Chemotherapy and Pharmacology
Yun Jung ChoiJae Cheol Lee

Abstract

H1650 non-small cell lung cancer (NSCLC) cells display primary resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) although they have a deletion mutation on exon 19 of the EGFR gene. We investigated the effect of inhibition of both insulin-like growth factor receptor (IGFR) and EGFR signaling considering that IGFR signaling pathway has been implicated in the development and progression with therapeutic resistance of various cancers including lung cancer. Three human NSCLC cell lines with an EGFR mutation of PC-9, HCC827 and H1650 were used for experiment. Cell viability and proliferative activity were assessed by MTT and three-dimensional culture assay. Combination index was obtained by CalcuSyn software. The change of EGFR- and IGFR-related signals was evaluated by western blots. H1650 cells were 1,000 times more resistant to gefitinib and erlotinib than HCC827 and PC-9 cells possessing the same EGFR mutation. Phosphatase and tensin homolog loss and sustained phosphorylation of Akt in spite of treatment with gefitinib were evident only in H1650 cells. Interestingly, IGFR phosphorylation was decreased by gefitinib in HCC827 and PC-9 cells while being maintained in H1650 cells. Combined treatmen...Continue Reading

References

Mar 7, 1997·The Journal of Biological Chemistry·S A CoolicanJ R Florini
May 5, 1999·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·T PetleyJ Florini
May 28, 2003·Cancer Letters·Derek LeRoith, Charles T Roberts
Jul 2, 2004·Nature Reviews. Cancer·Michael N PollakSusan E Hankinson
Aug 5, 2004·Journal of the National Cancer Institute·Federico CappuzzoLucio Crinò
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Feb 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey A EngelmanLewis C Cantley
Apr 1, 2006·Current Medical Research and Opinion·Keunchil Park, Koichi Goto
Aug 15, 2006·The Journal of Clinical Investigation·Jeffrey A EngelmanPasi A Jänne
Feb 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistDaniel A Haber
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Floriana MorgilloHo-Young Lee
Jun 24, 2008·The Journal of Clinical Investigation·Marta GuixJeffrey A Engelman
Jan 1, 2009·International Journal of Cancer. Journal International Du Cancer·Takafumi KuboShinichi Toyooka
Feb 10, 2009·Clinical Chemistry·Coren A MilburyG Mike Makrigiorgos

❮ Previous
Next ❯

Citations

May 1, 2012·Journal of Oncology·Yuh BabaYasumasa Kato
Mar 13, 2014·PloS One·Tao PanSuzhan Zhang
Mar 26, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xing-Xing FanElaine Lai-Han Leung
Jan 13, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Andrew WeickhardtD Ross Camidge
Feb 20, 2016·International Journal of Molecular Sciences·Thomas K SinBenjamin Y M Yung
Mar 1, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Go Woon KimJae Cheol Lee
Dec 1, 2017·PloS One·Chin Chun OoiShan X Wang
Oct 15, 2010·Expert Review of Anticancer Therapy·Rizwan SheikhRay McDermott
May 4, 2011·Current Opinion in Pulmonary Medicine·Tapan K MukherjeeSrirupa Mukhopadhyay
May 11, 2011·Clinical Pharmacokinetics·Matthias SchefflerUwe Fuhr
Nov 16, 2016·ESMO Open·Floriana MorgilloFortunato Ciardiello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Ryoichi OnozatoTetsuya Mitsudomi
Annals of Oncology : Official Journal of the European Society for Medical Oncology
P A ZucaliGiuseppe Giaccone
© 2022 Meta ULC. All rights reserved